• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微转移中药物诱导的耐药性:时空细胞谱系分析

Drug-Induced Resistance in Micrometastases: Analysis of Spatio-Temporal Cell Lineages.

作者信息

Pérez-Velázquez Judith, Rejniak Katarzyna A

机构信息

Mathematical Modeling of Biological Systems, Centre for Mathematical Science, Technical University of Munich, Garching, Germany.

Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.

出版信息

Front Physiol. 2020 Apr 17;11:319. doi: 10.3389/fphys.2020.00319. eCollection 2020.

DOI:10.3389/fphys.2020.00319
PMID:32362836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7180185/
Abstract

Resistance to anti-cancer drugs is a major cause of treatment failure. While several intracellular mechanisms of resistance have been postulated, the role of extrinsic factors in the development of resistance in individual tumor cells is still not fully understood. Here we used a hybrid agent-based model to investigate how sensitive tumor cells develop drug resistance in the heterogeneous tumor microenvironment. We characterized the spatio-temporal evolution of lineages of the resistant cells and examined how resistance at the single-cell level contributes to the overall tumor resistance. We also developed new methods to track tumor cell adaptation, to trace cell viability trajectories and to examine the three-dimensional spatio-temporal lineage trees. Our findings indicate that drug-induced resistance can result from cells adaptation to the changes in drug distribution. Two modes of cell adaptation were identified that coincide with microenvironmental niches-areas sheltered by cell micro-communities (protectorates) or regions with limited drug penetration (refuga or sanctuaries). We also recognized that certain cells gave rise to lineages of resistant cells (precursors of resistance) and pinpointed three temporal periods and spatial locations at which such cells emerged. This supports the hypothesis that tumor micrometastases do not need to harbor cell populations with pre-existing resistance, but that individual tumor cells can adapt and develop resistance induced by the drug during the treatment.

摘要

抗癌药物耐药性是治疗失败的主要原因。虽然已经提出了几种细胞内耐药机制,但外在因素在单个肿瘤细胞耐药性发展中的作用仍未完全了解。在这里,我们使用了一种基于混合代理的模型来研究敏感肿瘤细胞如何在异质性肿瘤微环境中产生耐药性。我们描述了耐药细胞谱系的时空演变,并研究了单细胞水平的耐药性如何导致整体肿瘤耐药性。我们还开发了新的方法来追踪肿瘤细胞的适应性、追踪细胞活力轨迹以及检查三维时空谱系树。我们的研究结果表明,药物诱导的耐药性可能源于细胞对药物分布变化的适应。确定了两种细胞适应模式,它们与微环境生态位相吻合——由细胞微群落(保护区)庇护的区域或药物渗透有限的区域(避难所或庇护所)。我们还认识到,某些细胞产生了耐药细胞谱系(耐药前体),并确定了这些细胞出现的三个时间段和空间位置。这支持了这样一种假设,即肿瘤微转移不需要含有预先存在耐药性的细胞群体,而是单个肿瘤细胞可以在治疗过程中适应并产生由药物诱导的耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/6a976819d23b/fphys-11-00319-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/c3554fcb4f56/fphys-11-00319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/82781ae6aaf1/fphys-11-00319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/99634b442dd2/fphys-11-00319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/6bf87eff9463/fphys-11-00319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/6a976819d23b/fphys-11-00319-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/c3554fcb4f56/fphys-11-00319-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/82781ae6aaf1/fphys-11-00319-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/99634b442dd2/fphys-11-00319-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/6bf87eff9463/fphys-11-00319-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa7/7180185/6a976819d23b/fphys-11-00319-g005.jpg

相似文献

1
Drug-Induced Resistance in Micrometastases: Analysis of Spatio-Temporal Cell Lineages.微转移中药物诱导的耐药性:时空细胞谱系分析
Front Physiol. 2020 Apr 17;11:319. doi: 10.3389/fphys.2020.00319. eCollection 2020.
2
Microenvironmental Niches and Sanctuaries: A Route to Acquired Resistance.微环境生态位与庇护所:获得性耐药的一条途径。
Adv Exp Med Biol. 2016;936:149-164. doi: 10.1007/978-3-319-42023-3_8.
3
Visualizing the Spatio-Temporal Dynamics of Clonal Evolution with software.使用软件可视化克隆进化的时空动态
bioRxiv. 2024 Mar 7:2024.03.05.583631. doi: 10.1101/2024.03.05.583631.
4
LinG3D: visualizing the spatio-temporal dynamics of clonal evolution.LinG3D:可视化克隆进化的时空动态。
BMC Bioinformatics. 2024 May 27;25(1):201. doi: 10.1186/s12859-024-05813-7.
5
Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases.在微转移空间模型中限制抗癌药物耐药性的发展。
Math Biosci Eng. 2016 Dec 1;13(6):1185-1206. doi: 10.3934/mbe.2016038.
6
Agent-Based Models Help Interpret Patterns of Clinical Drug Resistance by Contextualizing Competition Between Distinct Drug Failure Modes.基于主体的模型通过将不同药物失效模式之间的竞争情境化来帮助解释临床耐药模式。
Cell Mol Bioeng. 2022 Nov 15;15(5):521-533. doi: 10.1007/s12195-022-00748-6. eCollection 2022 Oct.
7
Spatio-Temporal Distribution Characteristics and Trajectory Similarity Analysis of Tuberculosis in Beijing, China.中国北京肺结核的时空分布特征及轨迹相似性分析
Int J Environ Res Public Health. 2016 Mar 7;13(3):291. doi: 10.3390/ijerph13030291.
8
Diffusion-driven enhancement of the antibiotic resistance selection window.扩散驱动增强抗生素耐药性选择窗口。
J R Soc Interface. 2019 Sep 27;16(158):20190363. doi: 10.1098/rsif.2019.0363. Epub 2019 Sep 11.
9
Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.用于监测肿瘤内演变的定量临床成像方法
Methods Mol Biol. 2017;1513:61-81. doi: 10.1007/978-1-4939-6539-7_6.
10
Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.基于图像的肿瘤异质血管中药物输送的时空模型 - 计算方法。
Microvasc Res. 2019 May;123:111-124. doi: 10.1016/j.mvr.2019.01.005. Epub 2019 Jan 31.

引用本文的文献

1
Validating the predictions of mathematical models describing tumor growth and treatment response.验证描述肿瘤生长和治疗反应的数学模型的预测结果。
ArXiv. 2025 Feb 26:arXiv:2502.19333v1.
2
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma.细胞骨架基因改变与肝癌索拉非尼耐药相关。
World J Surg Oncol. 2024 Jun 7;22(1):152. doi: 10.1186/s12957-024-03417-2.
3
LinG3D: visualizing the spatio-temporal dynamics of clonal evolution.LinG3D:可视化克隆进化的时空动态。

本文引用的文献

1
Hybrid modeling frameworks of tumor development and treatment.肿瘤发展和治疗的混合建模框架。
Wiley Interdiscip Rev Syst Biol Med. 2020 Jan;12(1):e1461. doi: 10.1002/wsbm.1461. Epub 2019 Jul 17.
2
Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.区分癌症治疗期间自发和诱导产生耐药性进化的数学方法。
JCO Clin Cancer Inform. 2019 Apr;3:1-20. doi: 10.1200/CCI.18.00087.
3
Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue.
BMC Bioinformatics. 2024 May 27;25(1):201. doi: 10.1186/s12859-024-05813-7.
4
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease.骨生态系统促进多发性骨髓瘤复发和异质性耐药疾病的演变。
Nat Commun. 2024 Mar 19;15(1):2458. doi: 10.1038/s41467-024-46594-0.
5
Histology-guided mathematical model of tumor oxygenation: sensitivity analysis of physical and computational parameters.组织学引导的肿瘤氧合数学模型:物理和计算参数的敏感性分析
bioRxiv. 2024 Mar 10:2024.03.05.583363. doi: 10.1101/2024.03.05.583363.
6
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics.转移灶间和转移灶内异质性塑造适应性治疗循环动力学。
Cancer Res. 2023 Aug 15;83(16):2775-2789. doi: 10.1158/0008-5472.CAN-22-2558.
7
Data-driven spatio-temporal modelling of glioblastoma.胶质母细胞瘤的数据驱动时空建模
R Soc Open Sci. 2023 Mar 22;10(3):221444. doi: 10.1098/rsos.221444. eCollection 2023 Mar.
8
Efficient Bayesian inference for stochastic agent-based models.基于代理的随机模型的高效贝叶斯推断。
PLoS Comput Biol. 2022 Oct 5;18(10):e1009508. doi: 10.1371/journal.pcbi.1009508. eCollection 2022 Oct.
9
Drug-induced resistance evolution necessitates less aggressive treatment.药物诱导的耐药性进化需要采取不那么激进的治疗方法。
PLoS Comput Biol. 2021 Sep 23;17(9):e1009418. doi: 10.1371/journal.pcbi.1009418. eCollection 2021 Sep.
10
Collective Cell Migration in a Fibrous Environment: A Hybrid Multiscale Modelling Approach.纤维环境中的集体细胞迁移:一种混合多尺度建模方法。
Front Appl Math Stat. 2021 Jun;7. doi: 10.3389/fams.2021.680029. Epub 2021 Jun 25.
微药物学:一种在肿瘤组织中评估药物疗效的计算方法。
Bull Math Biol. 2019 Sep;81(9):3623-3641. doi: 10.1007/s11538-018-0402-x. Epub 2018 Feb 8.
4
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.单细胞分析解决了与黑色素瘤药物诱导耐药相关的细胞状态转变和信号转导动态。
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13679-13684. doi: 10.1073/pnas.1712064115. Epub 2017 Dec 11.
5
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.适应性表型导致前列腺癌对雄激素剥夺疗法的耐药性。
Cell Commun Signal. 2017 Dec 8;15(1):51. doi: 10.1186/s12964-017-0206-x.
6
Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.建模化疗下实体瘤异质性的动态变化。
Bull Math Biol. 2017 Dec;79(12):2986-3012. doi: 10.1007/s11538-017-0359-1. Epub 2017 Oct 11.
7
Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.基于动态对比增强 MRI 的肿瘤靶区勾画。
Sci Rep. 2017 Aug 29;7(1):9746. doi: 10.1038/s41598-017-09932-5.
8
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.肿瘤在低氧微环境中的重编程:新兴概念及相关治疗策略。
Trends Pharmacol Sci. 2017 Aug;38(8):669-686. doi: 10.1016/j.tips.2017.05.002. Epub 2017 Jun 12.
9
Cancer: Tumours build their niche.癌症:肿瘤构建自身的生态位。
Nature. 2017 May 18;545(7654):292-293. doi: 10.1038/nature22494. Epub 2017 May 10.
10
Modeling multi-mutation and drug resistance: analysis of some case studies.多突变与耐药性建模:一些案例研究分析
Theor Biol Med Model. 2017 Mar 21;14(1):6. doi: 10.1186/s12976-017-0052-y.